Clinic Financial Model Excel Template v10 DEMO

All cells are locked for your safety
some changes in the model, you

your safety. If you would need to make
model, you should unlock cells for tab.
Model Name
Model Name
Go to the Table of Contents
Built with finmodelslab.com template Cover 09/22/2021

Table of Contents - Section & Sheet Titles
Model Name
Go to the Cover Sheet
1 Reports What each tab does

a. Financial Statements Summary On this tab you may get a quick glance at your Financial Statement Summary and have
a. a better understanding of the Income Statement, Cash Flow, and the Balance Sheet
a. as well as the Monthly view of a fiscal year, and the annual view of the five-year forecast.
b. DashBoard DashBoard tab gives you a snapshot of your business financial viability.
b. Core Financials, Cash Flow data, Revenue Breakdown, Profitability forecasts, and
b. cumulative Cash Flow are shown there.
c. Top Revenue Disease #1 and Disease #2 revenue are shown here by years.
d. Top Expenses This tab displays your 4 (four) biggest expense categories and the rest of the cost as the "other".
e. Break Even Analysis Here you can compare your overall revenues with the expenses.
f. Valuation Displays your company’s estimated value based on Discounted Cash Flow method.
g. Financial Charts On this tab you can visually track your key financial figures in form of charts.
h. Operational Charts Here you may visually track your key performance indicators in form of charts.
2 Assumptions and calculations
a. Revenue Calculation The key sheet which generates revenue in this model.
b. Fixed Expenses Enter fixed expenses and their annual growth rate.
c. Wages Fields to enter your employees assumptions: annual salary, taxes,
c. hire/fire dates, would-be annual FTEs, etc.
d. Variable Expenses Here you can fill up your variable expenses associated with revenue.
e. Development Expenses Here you can input Capital Expenses (CAPEX) for the clinic.
f. Capitalization Table Shareholder's ownership dilution is calculated here. This tab consists of 4 rounds of financing.
g. Book Assets Here you check internal calculations of the assets depreciation and the closing book value.
3 Statements
a. Income Statement On this tab you can see the monthly Income Statement report - Revenue, EBITDA, Net Profit.
b. Cash Flow Statement Here you can have a comprehensive Monthly Cash Flow Statement.
c. Cash Flow Statement (indirect method)
Here you can have a comprehensive Monthly Cash Flow Statement (indirect method).
d. Balance Sheet The Balance Sheet Statement. Assets, Liabilities, and Equity are displayed.
e. Capital Here you see internal calculations of the loans, interest, and equity.
e. In case of capital return, please, use yellow entry line.
f. Outputs This is the engine of this tool. All core calculations are done here.
4 Setup
a. Time Series The tab to set up: Fiscal Year End, First Fiscal Year.
Built with finmodelslab.com template Table of Contents 09/22/2021

Change Log
Model Name
v.9 - 22 Apr 2019

- Asset depreciation fixed
v.7 - 11 Mar 2019

- CF indirect method added
v.6 - 20 Feb 2019

- Capital timeline fixed
v.4 - 3 Jan 2019

- Graphs view improved
- Patience count calculation improved
- Visit count calculation improved
- Loan calculation improved
- Input and Output currency added
- Currency exchange rate added
- Denomination improved
v.1 - 22 Oct 2018

- CapTable added
- Financial charts added
- Operational charts added
- Operational charts added
- Breakeven Analysis added
- How-to section added
- Variable Expenses section added
- Fixed Expenses section improved
- Wages section improved
- Fiscal year feature added
- Overall calculations changed to monthly base
- Currency sign added
- Denominator feature added
- MAC supported
Built with finmodelslab.com template Change Log 09/22/2021

Information
Model Name
CLINIC FINANCIAL MODEL

v9.0
by Finmodelslab
https://finmodelslab.com/
henry@finmodelslab.com / @finmodelslab
Questions, comments, ideas, email henry@finmodelslab.com
GOAL
The goal of this model is to create an easy way for anyone to model a clinic startup business.
HOW TO USE
A) The Contents tab explains the different sheets,
the How-To sheet is the best place to start to understand how the model works,
it has detailed instructions on each sheet in the model.
B) Any number in blue with the yellow shaded background is an assumption that can be changed,
anything in with grey shaded background or black is the result of a formula.
C) Assumptions are on the yellow sheets, other specific assumptions to edit are on individual sheets highlighted in yellow.
D) All assumptions are dummy data only, do not assume they are market data or standard.
E) This model is built to adjust some business decisions very flexible:
- when the model starts,
- when the business begins,
- what currency sign to use.
F) You should tweak the revenue model to accurately model your business.
NEED ASSISTANCE?
For support questions, email henry@finmodelslab.com anytime.
For assistance in leveraging the models for individualized, personalized models to fit your business questions,
details at https://finmodelslab.com/financial-modeling-forecasting/
WARRANTIES & TERMS OF USE

Terms of Use and Warranties are located at https://finmodelslab.com/terms-of-service/
Purchase, download, or use of this model signifies acceptance of terms specified at https://finmodelslab.com/terms-of-service/
Copyright 2018 Finmodelslab, LLC
Built with finmodelslab.com template Information 09/22/2021

How To
Model Name
This is a guide on how to use the model.

For more information, consult https://finmodelslab.com or email henry@finmodelslab.com for support.
Overall Business Model Principles

The Clinic Financial Model is designed to forecast an up to 60-month operating budget and
cash flows with a simple set of assumptions around hiring and expenses.
Cover
Here you may type in a name for your business model.
Time Series
Fiscal Year end in the business model - input the last month of the Fiscal Year.
If you don't need this, simply type in Dec.
Initial Fiscal Year in the business model - please, choose your first Fiscal Year.
If you have chosen Dec in the Fiscal Year End than your fiscal year corresponds to the calendar year.
DashBoard
Here on this tab you can plan would-be income of your clinic,
The Population - starting population as well as annual growth rate
The Diseased, % - How many percentage people of the population has this disease?
The Our Patients, % - How many percentage people will use your services from the diseased population?
as well as the Patients Growth Rate by years, # of Visits per Patient per year for each Patient and Price per Visit
More to it, you can forecast loan/grant acquisition and loan repayment for the next few years.
In addition, you may take into a consideration currency exchange rate and estimate all outputs in a different currency.
Core revenue assumptions are:

Initial population and estimated population growth
Patient base assumptions - in this table you have the option to enter two names of diseases.
Then input percentage of population who has this kind of disease.
After, input the Our Patients, % which is the percentage of cases who will use your services.
Moreover, you have to enter the annual number of a visit and price per visit for each chronic disease.
At the Patient Growth Rate table you should enter the expected growth of your market share.
In this way Our Patients, % will increase over years.
Then, input Visits per one patient per year for each disease/treatment.
Finally, you should enter prices for each disease/treatment.
CURRENCY, DENOMINATOR and TAX:

Input Currency - insert the currency sign $/€/¥/£ or type in USD/EUR/GBP or any other abbreviation.
Output Currency - insert the currency sign $/€/¥/£ or type in USD/EUR/GBP or any other abbreviation.
Currency Exchange Rate - Enter your up-to-date exchange rate of the outputs currency in which you want to display reports.
Denomination - use it if you want to show outputs in thousands, millions or billions.
The Corporate Tax Rate will be applied to the annual profit before tax
Debt assumption - here you have the option to enter 3 debt and a grant.
For a grant, you just need to input an amount and select launch date.
Variable Expenses
Enter in the list of variable expenses you want to forecast in the rows Variable expense.
And type in the percentage of revenue to be spent or a cost per visit each category of diseases.
Fixed Expenses
On this tab you can enter forecasted different fixed expenses in order to start running the business.
You have multiple options of when to start to accrue the expense and when to end accruing.
You may define periodicity of the accrue for each expense.
It could be one-time, daily, weekly, bi-weekly, monthly, quarterly and etc.. This gives you the flexibility to manage expenses.
Wages
The wages tab easily allows you to calculate the expenses for the salaries of your personnel.
Use 1 line per employee/category and simply type in the hire date, fire date, and annual salary.
Next use the Number of Employees section to type in FTE count for each year.
Built with finmodelslab.com template How to 09/22/2021

How To
Model Name
An increase of FTEs means that you are going to hire additional FTE's.
In case of decrease FTEs means you fired some FTEs. New FTEs will be hired/fired on Jan of the relevant year.
If there are raises or changes in salaries, simply type in the Annual Salary Raise appropriate figures.
The program will automatically recalculate the changes made.
Finally, there are Monthly Bonus and Tax Rate columns where you can enter percentage of respective expenses.
Development Expenses
On this sheet you can see a table of clinic capital expenses.
You have to name categories, choose payment delay, and input the amount of expenses.
Capitalization Table
CapTable require some manual manipulation to be accurate.
The structure enables you to make the necessary modifications.
The CapTable takes you through multiple rounds of financings.
Showing how issued shares to new investors and cost per share impact the investment income.
After each round you will see the ownership, % changes. This is how the dilution works.
Financial Statements Summary

The Summary sheet is a Summary of the key financial reports of your business model.
In addition you have the options to select a year to see detailed outputs.
Top Revenue
Here you can track how much money each category generates.
Top Expenses
Here you can track during the 5-year period 4 biggest expense categories and the "other" which is the rest of the expenses.
Break Even Analysis

Here you can track when your company is supposed to move to a new level.
When its overall revenues become bigger than expenses.
Valuation
Here you can evaluate distribution of current cash flow to Investors - Discounted Cash Flow method.
Financial Charts
Here you can visually track key financial performance over the five years period as well as 24 months period.
Operational Charts
On this tab you can track some internal operational indexes that can be useful for analysis of the internal activity of the clinic.
Learn more at https://finmodelslab.com or email henry@finmodelslab.com with questions.
Built with finmodelslab.com template How to 09/22/2021

Time Series
Model Name
Time Series - Assumptions
Fiscal Year End December

First Fiscal Year 2019
Model Start Date 1-Jan-19
Model End Date 31-Dec-23
Built with finmodelslab.com template Time Series 09/22/2021

DashBoard CURRENCY, DENOMINATOR AND TAX DEBT ASSUMPTIONS
Model Name Currency Inputs $ Loan Name Amount, $ Launch Term, M Interest, % Select Type
Go to the Table of Contents Currency Outputs $ Debt_1 50,000 Jan-19 36 10% Usual Min Cash Month Sep-19
Denomination 1,000 Debt_2 Min Cash ($'000) -1,031.5
Currency exchange rate $ / $ 1.000 Debt_3
Corporate tax, % 10% Grant 75,000 Oct-20
Core Inputs Revenue Breakdown ($'000) - 5 Years to December 2023 Profitability ($'000) - 5 Years to December 2023
Population Growth
2019 2020 2021 2022 2023
Starting Point Population 80,000
Population growth rate 5% 5% 5% 5%
Forecasted population 84,000 88,200 92,610 97,240
Patient base assumptions
Disease name Diseased, % Our Patients, %
Disease #1 5.00% 35.00%
Disease #2 15.00% 15.00%
Patient Growth Rate
2019 2020 2021 2022 2023
Disease #1 1% 2% 2% 3%
Disease #2 1% 1% 1% 1%
Annual visits
2019 2020 2021 2022 2023
# of visits per Disease #1 patient 30 30 30 30 30
# of visits per Disease #2 patient 25 25 25 25 25
Price per visit, $
2019 2020 2021 2022 2023
Disease #1 70.0 70.0 75.0 75.0 75.0
Disease #2 30.0 30.0 30.0 30.0 30.0
Core Financials ($'000) Cash flow ($'000) - 5 Years to December 2023 Cumulative Cash flow ($'000) - 5 Years to December 2023
Fiscal Year 2019 2020 2021 2022 2023
Revenue 2,324 4,505 5,207 5,773 6,442
Variable Expenses (589) (1,141) (1,262) (1,399) (1,562)
GROSS MARGIN 1,734 3,364 3,945 4,374 4,881
GROSS MARGIN % 75% 75% 76% 76% 76%
Salaries & Wages (499) (583) (795) (873) (990)
Fixed Expenditure (2,148) (2,169) (2,191) (2,213) (2,235)
NET MARGIN (912) 612 959 1,289 1,656
NET MARGIN % 0% 14% 18% 22% 26%
EBITDA (912) 612 959 1,289 1,656
EBITDA % 0% 14% 18% 22% 26%
Depreciation & Amortization (59.2) (23.8) - - -
EBIT (971) 588 959 1,289 1,656
Net Interest Expense (4) (3) (1) (0) -
Net Profit Before Tax (975) 586 958 1,289 1,656
Tax Expense - (59) (96) (129) (166)
Net Profit After Tax (975) 527 862 1,160 1,490
Net Profit After Tax % 0% 12% 17% 20% 23%
Operating Cash Flows (916) 551 862 1,160 1,490
Cash (964) (355) 490 1,648 3,138
Built with finmodelslab.com template Dashboard 09/22/2021

Model Name Select detailed year: 2019
Income Statement ($'000) - 5 Years to December 2023 Income Statement ($'000) - 2019
Year Ending 2019 2020 2021 2022 2023 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Revenue 2,324 4,505 5,207 5,773 6,442 30 60 89 119 149 179 209 238 268 298 328 358
Growth % 94% 16% 11% 12% - 100% 50% 33% 25% 20% 17% 14% 13% 11% 10% 9%
Variable Expenses (589) (1,141) (1,262) (1,399) (1,562) (8) (15) (23) (30) (38) (45) (53) (60) (68) (76) (83) (91)
% of Revenue (25%) (25%) (24%) (24%) (24%) (25%) (25%) (25%) (25%) (25%) (25%) (25%) (25%) (25%) (25%) (25%) (25%)
GROSS MARGIN 1,734 3,364 3,945 4,374 4,881 22 44 67 89 111 133 156 178 200 222 245 267
GROSS MARGIN % 75% 75% 76% 76% 76% 75% 75% 75% 75% 75% 75% 75% 75% 75% 75% 75% 75%
Salaries & Wages (499) (583) (795) (873) (990) (42) (42) (42) (42) (42) (42) (42) (42) (42) (42) (42) (42)
% of Revenue (21%) (13%) (15%) (15%) (15%) (139%) (70%) (46%) (35%) (28%) (23%) (20%) (17%) (15%) (14%) (13%) (12%)
Fixed Expenses (2,148) (2,169) (2,191) (2,213) (2,235) (179) (179) (179) (179) (179) (179) (179) (179) (179) (179) (179) (179)
% of Revenue (92%) (48%) (42%) (38%) (35%) (601%) (300%) (200%) (150%) (120%) (100%) (86%) (75%) (67%) (60%) (55%) (50%)
EBITDA (912) 612 959 1,289 1,656 (198) (176) (154) (132) (109) (87) (65) (43) (20) 2 24 46
EBITDA % (39%) 14% 18% 22% 26% (666%) (296%) (172%) (110%) (73%) (49%) (31%) (18%) (8%) 1% 7% 13%
Depreciation & Amortization (59) (24) - - - (1) (1) (1) (1) (7) (7) (7) (7) (7) (7) (7) (7)
EBIT (971) 588 959 1,289 1,656 (199) (177) (155) (133) (116) (94) (72) (50) (27) (5) 17 39
Net Interest Expense (4) (3) (1) (0) - - (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Net Profit Before Tax (975) 586 958 1,289 1,656 (199) (177) (155) (133) (116) (94) (72) (50) (28) (5) 17 39
Tax Expense - (59) (96) (129) (166) - - - - - - - - - - - -
Net Profit After Tax (975) 527 862 1,160 1,490 (199) (177) (155) (133) (116) (94) (72) (50) (28) (5) 17 39
Net Profit After Tax % (42%) 12% 17% 20% 23% (668%) (298%) (174%) (112%) (78%) (53%) (35%) (21%) (10%) (2%) 5% 11%
Income Statement ($'000) - 5 Years to December 2023 Income Statement ($'000) - 2019
Built with finmodelslab.com template Financial Statements Summary 09/22/2021

Balance Sheet ($'000) - 5 Years to December 2023 Balance Sheet ($'000) - 2019
Current Assets (964) (355) 490 1,648 3,138 (158) (336) (494) (627) (738) (831) (900) (1,009) (1,031) (1,031) (1,009) (964)
Non-Current Assets 24 0 0 0 0 9 10 9 11 69 65 58 51 45 38 31 24
Total Assets (941) (355) 490 1,648 3,138 (149) (326) (485) (616) (669) (765) (842) (958) (987) (994) (978) (941)
Current Liabilities - - - - - - 2 - 3 68 68 65 - - - - -
Non-Current Liabilities 35 93 76 75 75 50 49 47 46 44 43 42 40 39 38 36 35
Total Liabilities 35 93 76 75 75 50 51 47 49 113 111 107 40 39 38 36 35
Net Assets (975) (448) 413 1,573 3,063 (199) (377) (532) (665) (782) (876) (948) (998) (1,026) (1,031) (1,014) (975)
Net Current Assets (964) (355) 490 1,648 3,138 (158) (338) (494) (631) (807) (898) (965) (1,009) (1,031) (1,031) (1,009) (964)
Ordinary Equity - - - - - - - - - - - - - - - - -
Other Equity - - - - - - - - - - - - - - - - -
Retained Profits (975) (448) 413 1,573 3,063 (199) (377) (532) (665) (782) (876) (948) (998) (1,026) (1,031) (1,014) (975)
Total Equity (975) (448) 413 1,573 3,063 (199) (377) (532) (665) (782) (876) (948) (998) (1,026) (1,031) (1,014) (975)
Balance Sheet ($'000) - 5 Years to December 2023 Balance Sheet ($'000) - 2019

Cash Flow Statement ($'000) - 5 Years to December 2023 Cash Flow Statement ($'000) - 2019
Cash Receipts 2,324 4,505 5,207 5,773 6,442 30 60 89 119 149 179 209 238 268 298 328 358
Cash Payments (3,236) (3,893) (4,249) (4,485) (4,786) (228) (236) (243) (251) (258) (266) (273) (281) (289) (296) (304) (311)
Other Operating Cash Flows (4) (61) (97) (129) (166) - (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Operating Cash Flows (916) 551 862 1,160 1,490 (198) (176) (154) (132) (110) (88) (65) (43) (21) 1 24 46
Capital Expenditure (83) - - - - (10) - (2) - - (3) (3) (65) - - - -
Other Investing Cash Flows - - - - - - - - - - - - - - - - -
Investing Cash Flows (83) - - - - (10) - (2) - - (3) (3) (65) - - - -
Debt Drawdowns/(Repayments) 35 58 (17) (1) - 50 (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1)
Equity Raisings/(Buybacks) - - - - - - - - - - - - - - - - -
Other Financing Cash Flows - - - - - - - - - - - - - - - - -
Financing Cash Flows 35 58 (17) (1) - 50 (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1)
Change in Cash Held (964) 609 845 1,158 1,490 (158) (178) (158) (133) (111) (92) (69) (109) (22) 0 22 45
Closing Cash (964) (355) 490 1,648 3,138 (158) (336) (494) (627) (738) (831) (900) (1,009) (1,031) (1,031) (1,009) (964)
Cash Flow Statement ($'000) - 5 Years to December 2023 Cash Flow Statement ($'000) - 2019

Top Revenue
Model Name
Revenue Summary ($'000) - 5 Years to December 2023
2019 2020 2021 2022 2023 2019 2020 2021 2022 2023
Disease #1 1,593 3,067 3,601 3,984 4,457 68.5% 68.1% 69.1% 69.0% 69.2%
Disease #2 731 1,438 1,607 1,789 1,985 31.5% 31.9% 30.9% 31.0% 30.8%
Total Revenue 2,324 4,505 5,207 5,773 6,442 100.0% 100.0% 100.0% 100.0% 100.0%
Revenue Summary ($'000) - 5 Years to December 2023
Revenue Depth ($'000) - 2019 Monthly Run-Rate ($'000) - 2019

2019
Revenue Bridge ($'000) - 2019 Total Revenue to 2023 Total Revenue

2019 2023
Built with finmodelslab.com template Top Revenue 09/22/2021

Top Expenses
Model Name
Top 5 Expense Categories ($'000) - 5 Years to December 2023
2019 2020 2021 2022 2023 2019 2020 2021 2022 2023
FC_Placeholder7 1,200 1,212 1,224 1,236 1,249 36.4% 30.5% 28.2% 26.8% 25.2%
Total Salary and Wages 499 583 795 873 990 15.1% 14.6% 18.3% 18.9% 20.0%
Rent 600 606 612 618 624 18.2% 15.2% 14.1% 13.4% 12.6%
VC_Placeholder3 228 438 480 531 594 6.9% 11.0% 11.0% 11.5% 12.0%
Other 773 1,139 1,234 1,355 1,495 23.4% 28.6% 28.4% 29.4% 30.2%
Total Expenses 3,299 3,978 4,346 4,613 4,952 100% 100% 100% 100% 100%
Top 5 Expense Categories ($'000) - 5 Years to December 2023
Expenses Depth ($'000) - 2019 Monthly Run-Rate ($'000) - 2019

2019
Expenses Bridge ($'000) - 2019 Total Expenses to 2023 Total Expenses

2019 2023
Built with finmodelslab.com template Top Expenses 09/22/2021

Break Even Analysis
Model Name
BREAK EVEN ($'000)
BREAK EVEN CALCULATION ($'000)
Year 2019 2020 2021 2022 2023
Revenue 2,324 4,505 5,207 5,773 6,442

Variable Expenses (589) (1,141) (1,262) (1,399) (1,562)
Gross Margin 1,734 3,364 3,945 4,374 4,881
EBITDA (912) 612 959 1,289 1,656
Break Even level 3,631 3,721 3,943 4,073 4,257
Net Profit Before Tax (975) 586 958 1,289 1,656
Net Profit Before Tax % 0.0% 13.0% 18.4% 22.3% 25.7%
Net Profit After Tax (975) 527 862 1,160 1,490
Net Profit After Tax % 0.0% 11.7% 16.5% 20.1% 23.1%
Built with finmodelslab.com template Break Even Analysis 09/22/2021

Valuation
Model Name
19.3104742034192
WACC Calculation
Cost of Capital
Risk-Free Rate 2.00% Share Cost Of Resources Tax Rate Wavg WACC
Inflation premium 3.00% Loans share 100.0% 10.00% 10.00% 9.0%
Risk premium 5.00% Equity share 0.0% 10.00%
Expected annual growth after 2022 3.00%
Free Cash Flow Calculation ($'000)

Free Cash Flow ($'000)
31-Dec-19 31-Dec-20 31-Dec-21 31-Dec-22 31-Dec-23
Fiscal year 2019 2020 2021 2022 2023
Operating Income (971) 588 959 1,289 1,656
Tax Expense - (59) (96) (129) (166)
Tax-Effected EBIT (Earnings Before Interest) (971) 530 863 1,160 1,490
Plus: Depreciation Expense 59 24 - - -
Capital Expenditures (83) - - - -
Inventory balance - - - - -
Accounts Receivable - - - - -
Current Liabilities - - - - -
Non-Current Liabilities (35) (93) (76) (75) (75)
Changes in Working Capital 35 58 (17) (1) -
Unlevered Free Cash Flow (961) 612 846 1,158 1,490
Free Cash Flow Valuation ($'000)
Discounted Cash Flow ($'000)

Fiscal year 2019 2020 2021 2022 2023
Terminal Value 25,580
Present Value of Unlevered Free Cash Flow (881) 515 653 821 17,594
NPV based on year 5 18,701

Multiplicator evaluation 19x
Built with finmodelslab.com template Valuation 09/22/2021

Financial Charts
Model Name
24 months 5 years
Built with finmodelslab.com template Financial Charts 09/22/2021

Financial Charts
Model Name
24 months 5 years
Built with finmodelslab.com template Financial Charts 09/22/2021

Operational Charts
Model Name
24 months 5 years
Built with finmodelslab.com template Operational Charts 09/22/2021

Operational Charts
Model Name
24 months 5 years
Built with finmodelslab.com template Operational Charts 09/22/2021

Income Statement
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
Month ### Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19
Income Statement ($)
Revenue
Disease #1 20,417 40,833 61,250 81,667 102,083 122,500 142,917 163,333 183,750 204,167 224,583 245,000
Disease #2 9,375 18,750 28,125 37,500 46,875 56,250 65,625 75,000 84,375 93,750 103,125 112,500
Total Revenue 29,792 59,583 89,375 119,167 148,958 178,750 208,542 238,333 268,125 297,917 327,708 357,500
Variable Expenses
Payment processing (745) (1,490) (2,234) (2,979) (3,724) (4,469) (5,214) (5,958) (6,703) (7,448) (8,193) (8,938)
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 (2,917) (5,833) (8,750) (11,667) (14,583) (17,500) (20,417) (23,333) (26,250) (29,167) (32,083) (35,000)
VC_Placeholder4 (2,333) (4,667) (7,000) (9,333) (11,667) (14,000) (16,333) (18,667) (21,000) (23,333) (25,667) (28,000)
VC_Placeholder5 (1,563) (3,125) (4,688) (6,250) (7,813) (9,375) (10,938) (12,500) (14,063) (15,625) (17,188) (18,750)
VC_Placeholder6 - - - - - - - - - - - -
Total Variable Expenses (7,557) (15,115) (22,672) (30,229) (37,786) (45,344) (52,901) (60,458) (68,016) (75,573) (83,130) (90,688)
GROSS MARGIN 22,234 44,469 66,703 88,938 111,172 133,406 155,641 177,875 200,109 222,344 244,578 266,813
Total Salary and Wages (41,543) (41,543) (41,543) (41,543) (41,543) (41,543) (41,543) (41,543) (41,543) (41,543) (41,543) (41,543)
Total Fixed Expenses (179,000) (179,000) (179,000) (179,000) (179,000) (179,000) (179,000) (179,000) (179,000) (179,000) (179,000) (179,000)
EBITDA (198,309) (176,075) (153,840) (131,606) (109,371) (87,137) (64,903) (42,668) (20,434) 1,800 24,035 46,269
Total Depreciation & Amortization (833) (1,008) (1,008) (1,275) (6,692) (6,917) (6,917) (6,917) (6,917) (6,917) (6,917) (6,917)
EBIT (199,142) (177,083) (154,849) (132,881) (116,063) (94,054) (71,819) (49,585) (27,351) (5,116) 17,118 39,353
Interest Expense - (417) (405) (394) (382) (370) (359) (347) (336) (324) (313) (301)
Net Profit Before Tax (199,142) (177,500) (155,254) (133,274) (116,445) (94,424) (72,178) (49,932) (27,686) (5,440) 16,806 39,052
Tax Expense at 12### - - - - - - - - - - - -
Net Profit After Tax (199,142) (177,500) (155,254) (133,274) (116,445) (94,424) (72,178) (49,932) (27,686) (5,440) 16,806 39,052
Built with finmodelslab.com template Income Statement 09/22/2021

Income Statement
Model Name
Fiscal Year 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
Revenue
Disease #1 246,633 248,267 249,900 251,533 253,167 254,800 256,433 258,067 259,700 261,333 262,967 264,600
Disease #2 113,625 114,750 115,875 117,000 118,125 119,250 120,375 121,500 122,625 123,750 124,875 126,000
Total Revenue 360,258 363,017 365,775 368,533 371,292 374,050 376,808 379,567 382,325 385,083 387,842 390,600
Variable Expenses
Payment processing (9,006) (9,075) (9,144) (9,213) (9,282) (9,351) (9,420) (9,489) (9,558) (9,627) (9,696) (9,765)
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 (35,233) (35,467) (35,700) (35,933) (36,167) (36,400) (36,633) (36,867) (37,100) (37,333) (37,567) (37,800)
VC_Placeholder4 (28,187) (28,373) (28,560) (28,747) (28,933) (29,120) (29,307) (29,493) (29,680) (29,867) (30,053) (30,240)
VC_Placeholder5 (18,938) (19,125) (19,313) (19,500) (19,688) (19,875) (20,063) (20,250) (20,438) (20,625) (20,813) (21,000)
VC_Placeholder6 - - - - - - - - - - - -
GROSS MARGIN 268,894 270,976 273,058 275,140 277,222 279,304 281,386 283,468 285,549 287,631 289,713 291,795
EBITDA 39,554 41,636 43,717 45,799 47,881 49,963 52,045 54,127 56,209 58,291 60,372 62,454
Total Depreciation & Amortization (6,083) (5,908) (5,908) (5,642) (225) - - - - - - -
EBIT 33,470 35,727 37,809 40,158 47,656 49,963 52,045 54,127 56,209 58,291 60,372 62,454
Interest Expense (289) (278) (266) (255) (243) (231) (220) (208) (197) (185) (174) (162)
Net Profit Before Tax 33,181 35,449 37,543 39,903 47,413 49,732 51,825 53,918 56,012 58,105 60,199 62,292
Tax Expense at 12### (3,318) (3,545) (3,754) (3,990) (4,741) (4,973) (5,183) (5,392) (5,601) (5,811) (6,020) (6,229)
Net Profit After Tax 29,863 31,904 33,789 35,913 42,672 44,758 46,643 48,527 50,411 52,295 54,179 56,063

Income Statement
Model Name
Fiscal Year 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021
Revenue
Disease #1 286,047 288,594 291,141 293,688 296,234 298,781 301,328 303,875 306,422 308,969 311,516 314,063
Disease #2 127,214 128,427 129,641 130,854 132,068 133,281 134,495 135,708 136,922 138,135 139,349 140,563
Total Revenue 413,260 417,021 420,781 424,542 428,302 432,063 435,823 439,583 443,344 447,104 450,865 454,625
Variable Expenses
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 (38,140) (38,479) (38,819) (39,158) (39,498) (39,838) (40,177) (40,517) (40,856) (41,196) (41,535) (41,875)
VC_Placeholder4 (30,512) (30,783) (31,055) (31,327) (31,598) (31,870) (32,142) (32,413) (32,685) (32,957) (33,228) (33,500)
VC_Placeholder5 (21,202) (21,405) (21,607) (21,809) (22,011) (22,214) (22,416) (22,618) (22,820) (23,023) (23,225) (23,427)
VC_Placeholder6 - - - - - - - - - - - -
GROSS MARGIN 313,075 315,928 318,781 321,634 324,487 327,340 330,193 333,046 335,899 338,751 341,604 344,457
EBITDA 64,189 67,042 69,895 72,748 75,600 78,453 81,306 84,159 87,012 89,865 92,718 95,571
Total Depreciation & Amortization - - - - - - - - - - - -
EBIT 64,189 67,042 69,895 72,748 75,600 78,453 81,306 84,159 87,012 89,865 92,718 95,571
Interest Expense (150) (139) (127) (116) (104) (93) (81) (69) (58) (46) (35) (23)
Tax Expense at 12### (6,404) (6,690) (6,977) (7,263) (7,550) (7,836) (8,123) (8,409) (8,695) (8,982) (9,268) (9,555)

Income Statement
Model Name
Fiscal Year 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022
Revenue
Disease #1 316,828 319,594 322,359 325,125 327,891 330,656 333,422 336,188 338,953 341,719 344,484 347,250
Disease #2 141,870 143,177 144,484 145,792 147,099 148,406 149,714 151,021 152,328 153,635 154,943 156,250
Total Revenue 458,698 462,771 466,844 470,917 474,990 479,063 483,135 487,208 491,281 495,354 499,427 503,500
Variable Expenses
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 (42,244) (42,613) (42,981) (43,350) (43,719) (44,088) (44,456) (44,825) (45,194) (45,563) (45,931) (46,300)
VC_Placeholder4 (33,795) (34,090) (34,385) (34,680) (34,975) (35,270) (35,565) (35,860) (36,155) (36,450) (36,745) (37,040)
VC_Placeholder5 (23,645) (23,863) (24,081) (24,299) (24,516) (24,734) (24,952) (25,170) (25,388) (25,606) (25,824) (26,042)
VC_Placeholder6 - - - - - - - - - - - -
GROSS MARGIN 347,547 350,636 353,726 356,815 359,905 362,994 366,084 369,173 372,262 375,352 378,441 381,531
EBITDA 90,391 93,481 96,570 99,660 102,749 105,839 108,928 112,018 115,107 118,197 121,286 124,375
EBIT 90,391 93,481 96,570 99,660 102,749 105,839 108,928 112,018 115,107 118,197 121,286 124,375
Interest Expense (12) - - - - - - - - - - -
Tax Expense at 12### (9,038) (9,348) (9,657) (9,966) (10,275) (10,584) (10,893) (11,202) (11,511) (11,820) (12,129) (12,438)

Income Statement
Model Name
Fiscal Year 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
Revenue
Disease #1 350,969 354,688 358,406 362,125 365,844 369,563 373,281 377,000 380,719 384,438 388,156 391,875
Disease #2 157,661 159,073 160,484 161,896 163,307 164,719 166,130 167,542 168,953 170,365 171,776 173,188
Total Revenue 508,630 513,760 518,891 524,021 529,151 534,281 539,411 544,542 549,672 554,802 559,932 565,063
Variable Expenses
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 (46,796) (47,292) (47,788) (48,283) (48,779) (49,275) (49,771) (50,267) (50,763) (51,258) (51,754) (52,250)
VC_Placeholder4 (37,437) (37,833) (38,230) (38,627) (39,023) (39,420) (39,817) (40,213) (40,610) (41,007) (41,403) (41,800)
VC_Placeholder5 (26,277) (26,512) (26,747) (26,983) (27,218) (27,453) (27,688) (27,924) (28,159) (28,394) (28,629) (28,865)
VC_Placeholder6 - - - - - - - - - - - -
GROSS MARGIN 385,405 389,279 393,153 397,028 400,902 404,776 408,650 412,525 416,399 420,273 424,147 428,021
EBITDA 116,664 120,538 124,412 128,286 132,161 136,035 139,909 143,783 147,658 151,532 155,406 159,280
EBIT 116,664 120,538 124,412 128,286 132,161 136,035 139,909 143,783 147,658 151,532 155,406 159,280
Interest Expense - - - - - - - - - - - -
Tax Expense at 12### (11,666) (12,054) (12,441) (12,829) (13,216) (13,603) (13,991) (14,378) (14,766) (15,153) (15,541) (15,928)

Cash Flow Statement
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
Month Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19
Cash Flow Statement ($)
Cash Flow from Operating Activities

Cash Receipts 29,792 59,583 89,375 119,167 148,958 178,750 208,542 238,333 268,125 297,917 327,708 357,500
Cash Payments (228,101) (235,658) (243,215) (250,773) (258,330) (265,887) (273,444) (281,002) (288,559) (296,116) (303,674) (311,231)
Interest Paid - (417) (405) (394) (382) (370) (359) (347) (336) (324) (313) (301)
Corporate Tax Paid - - - - - - - - - - - -
CASH INFLOW 29,792 59,583 89,375 119,167 148,958 178,750 208,542 238,333 268,125 297,917 327,708 357,500
CASH OUTFLOW (228,101) (236,075) (243,620) (251,166) (258,712) (266,257) (273,803) (281,349) (288,895) (296,440) (303,986) (311,532)
Net Cash Flow from Operating Activities (198,309) (176,491) (154,245) (131,999) (109,753) (87,507) (65,262) (43,016) (20,770) 1,476 23,722 45,968
Cash Flow from Investing Activities
Fixed Assets Capital Expenditure (10,000) - (2,100) - - (3,200) (2,700) (65,000) - - - -
Net Cash Flow from Investing Activities (10,000) - (2,100) - - (3,200) (2,700) (65,000) - - - -
Cash Flow from Financing Activities
Debt Drawdowns 50,000 - - - - - - - - - - -
Debt Repayments - (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389)
Ordinary Equity Raisings - - - - - - - - - - - -
Ordinary Equity Buybacks - - - - - - - - - - - -
Ordinary Equity Dividends Paid - - - - - - - - - - - -
Other Financing Cash Flows - - - - - - - - - - - -
Net Cash Flow from Financing Activities 50,000 (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389)
Net Increase/(Decrease) in Cash Held (158,309) (177,880) (157,734) (133,388) (111,142) (92,096) (69,350) (109,404) (22,158) 87 22,333 44,579
Interest on Cash Breakdown
Net Cash Flow from Investing Activities (10,000) - (2,100) - - (3,200) (2,700) (65,000) - - - -
Net Cash Flow from Financing Activities 50,000 (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389)
Cash Receipts 29,792 59,583 89,375 119,167 148,958 178,750 208,542 238,333 268,125 297,917 327,708 357,500
Cash Payments (228,101) (235,658) (243,215) (250,773) (258,330) (265,887) (273,444) (281,002) (288,559) (296,116) (303,674) (311,231)
Change in Cash (Pre-Corporate Tax & Interest on Cash) (158,309) (177,463) (157,329) (132,995) (110,760) (91,726) (68,992) (109,057) (21,823) 412 22,646 44,880
Interest Paid - (417) (405) (394) (382) (370) (359) (347) (336) (324) (313) (301)
Corporate Tax Paid - - - - - - - - - - - -
Net Increase/(Decrease) in Cash Held (158,309) (177,880) (157,734) (133,388) (111,142) (92,096) (69,350) (109,404) (22,158) 87 22,333 44,579
Built with finmodelslab.com template Cash Flow Statement 09/22/2021

Cash Flow Statement
Model Name
Fiscal Year 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020

Cash Receipts 360,258 363,017 365,775 368,533 371,292 374,050 376,808 379,567 382,325 385,083 387,842 390,600
Cash Payments (320,705) (321,381) (322,058) (322,734) (323,410) (324,087) (324,763) (325,440) (326,116) (326,793) (327,469) (328,146)
Interest Paid (289) (278) (266) (255) (243) (231) (220) (208) (197) (185) (174) (162)
Corporate Tax Paid (3,318) (3,545) (3,754) (3,990) (4,741) (4,973) (5,183) (5,392) (5,601) (5,811) (6,020) (6,229)
CASH INFLOW 360,258 363,017 365,775 368,533 371,292 374,050 376,808 379,567 382,325 385,083 387,842 390,600
CASH OUTFLOW (324,312) (325,204) (326,078) (326,979) (328,395) (329,292) (330,166) (331,040) (331,914) (332,789) (333,663) (334,537)
Net Cash Flow from Operating Activities 35,946 37,813 39,697 41,554 42,897 44,758 46,643 48,527 50,411 52,295 54,179 56,063
Fixed Assets Capital Expenditure - - - - - - - - - - - -
Net Cash Flow from Investing Activities - - - - - - - - - - - -
Debt Drawdowns - - - - - - - - - 75,000 - -
Debt Repayments (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389)
Net Cash Flow from Financing Activities (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) 73,611 (1,389) (1,389)
Net Increase/(Decrease) in Cash Held 34,557 36,424 38,308 40,165 41,508 43,370 45,254 47,138 49,022 125,906 52,790 54,674
Net Cash Flow from Financing Activities (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) 73,611 (1,389) (1,389)
Cash Receipts 360,258 363,017 365,775 368,533 371,292 374,050 376,808 379,567 382,325 385,083 387,842 390,600
Cash Payments (320,705) (321,381) (322,058) (322,734) (323,410) (324,087) (324,763) (325,440) (326,116) (326,793) (327,469) (328,146)
Change in Cash (Pre-Corporate Tax & Interest on Cash) 38,165 40,247 42,329 44,410 46,492 48,574 50,656 52,738 54,820 131,902 58,984 61,065
Interest Paid (289) (278) (266) (255) (243) (231) (220) (208) (197) (185) (174) (162)

Cash Flow Statement
Model Name
Fiscal Year 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021

Cash Receipts 413,260 417,021 420,781 424,542 428,302 432,063 435,823 439,583 443,344 447,104 450,865 454,625
Cash Payments (349,072) (349,979) (350,887) (351,794) (352,702) (353,609) (354,517) (355,424) (356,332) (357,239) (358,147) (359,054)
Interest Paid (150) (139) (127) (116) (104) (93) (81) (69) (58) (46) (35) (23)
CASH INFLOW 413,260 417,021 420,781 424,542 428,302 432,063 435,823 439,583 443,344 447,104 450,865 454,625
CASH OUTFLOW (355,626) (356,808) (357,991) (359,173) (360,355) (361,538) (362,720) (363,903) (365,085) (366,267) (367,450) (368,632)
Debt Drawdowns - - - - - - - - - - - -
Debt Repayments (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389)
Net Cash Flow from Financing Activities (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389)
Net Cash Flow from Financing Activities (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389)
Cash Receipts 413,260 417,021 420,781 424,542 428,302 432,063 435,823 439,583 443,344 447,104 450,865 454,625
Cash Payments (349,072) (349,979) (350,887) (351,794) (352,702) (353,609) (354,517) (355,424) (356,332) (357,239) (358,147) (359,054)
Interest Paid (150) (139) (127) (116) (104) (93) (81) (69) (58) (46) (35) (23)

Cash Flow Statement
Model Name
Fiscal Year 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022

Cash Receipts 458,698 462,771 466,844 470,917 474,990 479,063 483,135 487,208 491,281 495,354 499,427 503,500
Cash Payments (368,307) (369,290) (370,273) (371,257) (372,240) (373,224) (374,207) (375,191) (376,174) (377,158) (378,141) (379,125)
Interest Paid (12) - - - - - - - - - - -
CASH INFLOW 458,698 462,771 466,844 470,917 474,990 479,063 483,135 487,208 491,281 495,354 499,427 503,500
CASH OUTFLOW (377,356) (378,638) (379,931) (381,223) (382,515) (383,808) (385,100) (386,393) (387,685) (388,977) (390,270) (391,562)
Debt Drawdowns - - - - - - - - - - - -
Debt Repayments (1,389) - - - - - - - - - - -
Net Cash Flow from Financing Activities (1,389) - - - - - - - - - - -
Net Cash Flow from Financing Activities (1,389) - - - - - - - - - - -
Cash Receipts 458,698 462,771 466,844 470,917 474,990 479,063 483,135 487,208 491,281 495,354 499,427 503,500
Cash Payments (368,307) (369,290) (370,273) (371,257) (372,240) (373,224) (374,207) (375,191) (376,174) (377,158) (378,141) (379,125)
Interest Paid (12) - - - - - - - - - - -

Cash Flow Statement
Model Name
Fiscal Year 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023

Cash Receipts 508,630 513,760 518,891 524,021 529,151 534,281 539,411 544,542 549,672 554,802 559,932 565,063
Cash Payments (391,966) (393,222) (394,478) (395,734) (396,990) (398,246) (399,502) (400,758) (402,014) (403,270) (404,526) (405,782)
Interest Paid - - - - - - - - - - - -
CASH INFLOW 508,630 513,760 518,891 524,021 529,151 534,281 539,411 544,542 549,672 554,802 559,932 565,063
CASH OUTFLOW (403,633) (405,276) (406,920) (408,563) (410,206) (411,850) (413,493) (415,137) (416,780) (418,424) (420,067) (421,710)
Debt Drawdowns - - - - - - - - - - - -
Debt Repayments - - - - - - - - - - - -
Net Cash Flow from Financing Activities - - - - - - - - - - - -
Net Cash Flow from Financing Activities - - - - - - - - - - - -
Cash Receipts 508,630 513,760 518,891 524,021 529,151 534,281 539,411 544,542 549,672 554,802 559,932 565,063
Cash Payments (391,966) (393,222) (394,478) (395,734) (396,990) (398,246) (399,502) (400,758) (402,014) (403,270) (404,526) (405,782)
Interest Paid - - - - - - - - - - - -

Cash Flow Statement (indirect method)
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019

Model Name
Fiscal Year 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020

Model Name
Fiscal Year 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021

Model Name
Fiscal Year 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022

Model Name
Fiscal Year 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023

Balance Sheet
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
Balance Sheet ($)
Current Assets
Opening Cash - (158,309.0) (336,189.1) (493,923.3) (627,311.5) (738,453.8) (830,550.2) (899,900.6) (1,009,305.0) (1,031,463.5) (1,031,376.0) (1,009,042.6)
Change in Cash (158,309.0) (177,880.1) (157,734.2) (133,388.2) (111,142.3) (92,096.3) (69,350.4) (109,404.4) (22,158.5) 87.5 22,333.4 44,579.4
Cash (158,309) (336,189) (493,923) (627,312) (738,454) (830,550) (899,901) (1,009,305) (1,031,463) (1,031,376) (1,009,043) (964,463)
Total Current Assets (158,309) (336,189) (493,923) (627,312) (738,454) (830,550) (899,901) (1,009,305) (1,031,463) (1,031,376) (1,009,043) (964,463)
Non-Current Assets
Assets Closing Net Book Value 9,167 10,258 9,250 11,175 69,483 65,267 58,350 51,433 44,517 37,600 30,683 23,767
CAPEX Prepayment - - - - - - - - - - - -
Fixed Assets 9,167 10,258 9,250 11,175 69,483 65,267 58,350 51,433 44,517 37,600 30,683 23,767
Total Non-Current Assets 9,167 10,258 9,250 11,175 69,483 65,267 58,350 51,433 44,517 37,600 30,683 23,767
Total Assets (149,142) (325,931) (484,673) (616,137) (668,970) (765,283) (841,551) (957,872) (986,947) (993,776) (978,359) (940,697)
Current Liabilities
CAPEX Payble - 2,100 - 3,200 68,200 67,700 65,000 - - - - -
Corporate Tax Payable - - - - - - - - - - - -
Total Current Liabilities - 2,100 - 3,200 68,200 67,700 65,000 - - - - -
Non-Current Liabilities
Debt 50,000 48,611 47,222 45,833 44,444 43,056 41,667 40,278 38,889 37,500 36,111 34,722
Grant - - - - - - - - - - - -
Debt 50,000 48,611 47,222 45,833 44,444 43,056 41,667 40,278 38,889 37,500 36,111 34,722
Other Non-Current Liabilities Category 1 - - - - - - - - - - - -
Other Non-Current Liabilities - - - - - - - - - - - -
Total Non-Current Liabilities 50,000 48,611 47,222 45,833 44,444 43,056 41,667 40,278 38,889 37,500 36,111 34,722
Total Liabilities 50,000 50,711 47,222 49,033 112,644 110,756 106,667 40,278 38,889 37,500 36,111 34,722
Net Assets (199,142) (376,642) (531,896) (665,170) (781,615) (876,039) (948,217) (998,149) (1,025,836) (1,031,276) (1,014,470) (975,419)
Ordinary Equity - - - - - - - - - - - -
Retained Profits (199,142) (376,642) (531,896) (665,170) (781,615) (876,039) (948,217) (998,149) (1,025,836) (1,031,276) (1,014,470) (975,419)
Total Equity (199,142) (376,642) (531,896) (665,170) (781,615) (876,039) (948,217) (998,149) (1,025,836) (1,031,276) (1,014,470) (975,419)
Built with finmodelslab.com template Balance Sheet 09/22/2021

Balance Sheet
Model Name
Fiscal Year 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
Balance Sheet ($)
Current Assets
Opening Cash (964,463.3) (929,906.0) (893,482.0) (855,174.0) (815,008.5) (773,500.6) (730,131.0) (684,877.4) (637,739.7) (588,717.9) (462,811.9) (410,021.9)
Change in Cash 34,557.3 36,423.9 38,308.0 40,165.5 41,507.9 43,369.5 45,253.6 47,137.7 49,021.8 125,905.9 52,790.0 54,674.1
Cash (929,906) (893,482) (855,174) (815,008) (773,501) (730,131) (684,877) (637,740) (588,718) (462,812) (410,022) (355,348)
Total Current Assets (929,906) (893,482) (855,174) (815,008) (773,501) (730,131) (684,877) (637,740) (588,718) (462,812) (410,022) (355,348)
Non-Current Assets
Assets Closing Net Book Value 17,683 11,775 5,867 225 0 0 0 0 0 0 0 0
Fixed Assets 17,683 11,775 5,867 225 0 0 0 0 0 0 0 0
Total Non-Current Assets 17,683 11,775 5,867 225 0 0 0 0 0 0 0 0
Total Assets (912,223) (881,707) (849,307) (814,783) (773,501) (730,131) (684,877) (637,740) (588,718) (462,812) (410,022) (355,348)
Current Liabilities
CAPEX Payble - - - - - - - - - - - -
Total Current Liabilities - - - - - - - - - - - -
Debt 33,333 31,944 30,556 29,167 27,778 26,389 25,000 23,611 22,222 20,833 19,444 18,056
Grant - - - - - - - - - 75,000 75,000 75,000
Debt 33,333 31,944 30,556 29,167 27,778 26,389 25,000 23,611 22,222 95,833 94,444 93,056
Net Assets (945,556) (913,651) (879,863) (843,950) (801,278) (756,520) (709,877) (661,351) (610,940) (558,645) (504,466) (448,403)
Ordinary Equity - - - - - - - - - - - -
Retained Profits (945,556) (913,651) (879,863) (843,950) (801,278) (756,520) (709,877) (661,351) (610,940) (558,645) (504,466) (448,403)
Total Equity (945,556) (913,651) (879,863) (843,950) (801,278) (756,520) (709,877) (661,351) (610,940) (558,645) (504,466) (448,403)

Balance Sheet
Model Name
Fiscal Year 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021
Balance Sheet ($)
Current Assets
Opening Cash (355,347.7) (299,102.1) (240,278.4) (178,876.7) (114,896.9) (48,339.2) 20,796.6 92,510.4 166,802.3 243,672.2 323,120.1 405,146.0
Change in Cash 56,245.7 58,823.7 61,401.7 63,979.7 66,557.8 69,135.8 71,713.8 74,291.8 76,869.9 79,447.9 82,025.9 84,603.9
Cash (299,102) (240,278) (178,877) (114,897) (48,339) 20,797 92,510 166,802 243,672 323,120 405,146 489,750
Total Current Assets (299,102) (240,278) (178,877) (114,897) (48,339) 20,797 92,510 166,802 243,672 323,120 405,146 489,750
Non-Current Assets
Assets Closing Net Book Value 0 0 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Non-Current Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets (299,102) (240,278) (178,877) (114,897) (48,339) 20,797 92,510 166,802 243,672 323,120 405,146 489,750
Current Liabilities
CAPEX Payble - - - - - - - - - - - -
Debt 16,667 15,278 13,889 12,500 11,111 9,722 8,333 6,944 5,556 4,167 2,778 1,389
Grant 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000
Debt 91,667 90,278 88,889 87,500 86,111 84,722 83,333 81,944 80,556 79,167 77,778 76,389
Net Assets (390,769) (330,556) (267,766) (202,397) (134,450) (63,926) 9,177 84,858 163,117 243,953 327,368 413,361
Ordinary Equity - - - - - - - - - - - -
Retained Profits (390,769) (330,556) (267,766) (202,397) (134,450) (63,926) 9,177 84,858 163,117 243,953 327,368 413,361
Total Equity (390,769) (330,556) (267,766) (202,397) (134,450) (63,926) 9,177 84,858 163,117 243,953 327,368 413,361

Balance Sheet
Model Name
Fiscal Year 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022
Balance Sheet ($)
Current Assets
Opening Cash 489,749.9 569,702.8 653,835.6 740,748.8 830,442.6 922,916.9 1,018,171.6 1,116,207.0 1,217,022.8 1,320,619.1 1,426,996.0 1,536,153.4
Change in Cash 79,952.9 84,132.7 86,913.2 89,693.8 92,474.3 95,254.8 98,035.3 100,815.8 103,596.3 106,376.9 109,157.4 111,937.9
Cash 569,703 653,836 740,749 830,443 922,917 1,018,172 1,116,207 1,217,023 1,320,619 1,426,996 1,536,153 1,648,091
Total Current Assets 569,703 653,836 740,749 830,443 922,917 1,018,172 1,116,207 1,217,023 1,320,619 1,426,996 1,536,153 1,648,091
Non-Current Assets
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 569,703 653,836 740,749 830,443 922,917 1,018,172 1,116,207 1,217,023 1,320,619 1,426,996 1,536,153 1,648,091
Current Liabilities
CAPEX Payble - - - - - - - - - - - -
Debt (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Grant 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000
Debt 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000
Net Assets 494,703 578,836 665,749 755,443 847,917 943,172 1,041,207 1,142,023 1,245,619 1,351,996 1,461,153 1,573,091
Ordinary Equity - - - - - - - - - - - -
Retained Profits 494,703 578,836 665,749 755,443 847,917 943,172 1,041,207 1,142,023 1,245,619 1,351,996 1,461,153 1,573,091
Total Equity 494,703 578,836 665,749 755,443 847,917 943,172 1,041,207 1,142,023 1,245,619 1,351,996 1,461,153 1,573,091

Balance Sheet
Model Name
Fiscal Year 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
Balance Sheet ($)
Current Assets
Opening Cash 1,648,091.2 1,753,088.7 1,861,573.0 1,973,544.0 2,089,001.9 2,207,946.5 2,330,377.9 2,456,296.1 2,585,701.1 2,718,592.9 2,854,971.4 2,994,836.8
Change in Cash 104,997.5 108,484.3 111,971.0 115,457.8 118,944.6 122,431.4 125,918.2 129,405.0 132,891.8 136,378.6 139,865.4 143,352.1
Cash 1,753,089 1,861,573 1,973,544 2,089,002 2,207,946 2,330,378 2,456,296 2,585,701 2,718,593 2,854,971 2,994,837 3,138,189
Total Current Assets 1,753,089 1,861,573 1,973,544 2,089,002 2,207,946 2,330,378 2,456,296 2,585,701 2,718,593 2,854,971 2,994,837 3,138,189
Non-Current Assets
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1,753,089 1,861,573 1,973,544 2,089,002 2,207,946 2,330,378 2,456,296 2,585,701 2,718,593 2,854,971 2,994,837 3,138,189
Current Liabilities
CAPEX Payble - - - - - - - - - - - -
Debt (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Grant 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000
Debt 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000
Net Assets 1,678,089 1,786,573 1,898,544 2,014,002 2,132,946 2,255,378 2,381,296 2,510,701 2,643,593 2,779,971 2,919,837 3,063,189
Ordinary Equity - - - - - - - - - - - -
Retained Profits 1,678,089 1,786,573 1,898,544 2,014,002 2,132,946 2,255,378 2,381,296 2,510,701 2,643,593 2,779,971 2,919,837 3,063,189
Total Equity 1,678,089 1,786,573 1,898,544 2,014,002 2,132,946 2,255,378 2,381,296 2,510,701 2,643,593 2,779,971 2,919,837 3,063,189

Variable Expenses
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
Clinic Variable Expenses - Assumptions, $

Total Revenue 29,792 59,583 89,375 119,167 148,958 178,750 208,542 238,333 268,125 297,917 327,708 357,500
Disease #1 visit 292 583 875 1,167 1,458 1,750 2,042 2,333 2,625 2,917 3,208 3,500
Disease #2 visit 313 625 938 1,250 1,563 1,875 2,188 2,500 2,813 3,125 3,438 3,750
Categories Variable Expenses

Payment processing as % of Total Revenue 2.5%
VC_Placeholder2 as % of Total Revenue
VC_Placeholder3 as $ per Disease #1 visit 10.0
VC_Placeholder6 as $ per Disease #2 visit
Variable Expenses, $
Categories
Payment processing as % of Total Revenue 745 1,490 2,234 2,979 3,724 4,469 5,214 5,958 6,703 7,448 8,193 8,938
VC_Placeholder2 as % of Total Revenue - - - - - - - - - - - -
VC_Placeholder3 as $ per Disease #1 visit 2,917 5,833 8,750 11,667 14,583 17,500 20,417 23,333 26,250 29,167 32,083 35,000
VC_Placeholder5 as $ per Disease #2 visit 1,562.50 3,125 4,688 6,250 7,813 9,375 10,938 12,500 14,063 15,625 17,188 18,750
VC_Placeholder6 as $ per Disease #2 visit - - - - - - - - - - - -
Total Variable Expenses, $ 7,557 15,115 22,672 30,229 37,786 45,344 52,901 60,458 68,016 75,573 83,130 90,688
Built with finmodelslab.com template Variable Expenses 09/22/2021

Variable Expenses
Model Name
Fiscal Year 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020

Total Revenue 360,258 363,017 365,775 368,533 371,292 374,050 376,808 379,567 382,325 385,083 387,842 390,600
Disease #1 visit 3,523 3,547 3,570 3,593 3,617 3,640 3,663 3,687 3,710 3,733 3,757 3,780
Disease #2 visit 3,788 3,825 3,863 3,900 3,938 3,975 4,013 4,050 4,088 4,125 4,163 4,200
Categories
Payment processing as % of Total Revenue
Categories
Payment processing as % of Total Revenue 9,006 9,075 9,144 9,213 9,282 9,351 9,420 9,489 9,558 9,627 9,696 9,765

Variable Expenses
Model Name
Fiscal Year 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021

Total Revenue 413,260 417,021 420,781 424,542 428,302 432,063 435,823 439,583 443,344 447,104 450,865 454,625
Disease #1 visit 3,814 3,848 3,882 3,916 3,950 3,984 4,018 4,052 4,086 4,120 4,154 4,188
Disease #2 visit 4,240 4,281 4,321 4,362 4,402 4,443 4,483 4,524 4,564 4,605 4,645 4,685
Categories
Categories

Variable Expenses
Model Name
Fiscal Year 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022

Total Revenue 458,698 462,771 466,844 470,917 474,990 479,063 483,135 487,208 491,281 495,354 499,427 503,500
Disease #1 visit 4,224 4,261 4,298 4,335 4,372 4,409 4,446 4,483 4,519 4,556 4,593 4,630
Disease #2 visit 4,729 4,773 4,816 4,860 4,903 4,947 4,990 5,034 5,078 5,121 5,165 5,208
Categories
Categories

Variable Expenses
Model Name
Fiscal Year 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023

Total Revenue 508,630 513,760 518,891 524,021 529,151 534,281 539,411 544,542 549,672 554,802 559,932 565,063
Disease #1 visit 4,680 4,729 4,779 4,828 4,878 4,928 4,977 5,027 5,076 5,126 5,175 5,225
Disease #2 visit 5,255 5,302 5,349 5,397 5,444 5,491 5,538 5,585 5,632 5,679 5,726 5,773
Categories
Categories

Fixed Expenses
Model Name
Fixed Expenses & Growth rates - Assumptions, $

Yearly Growth Rate
Categories Launch date End date Periodicity Spending, $ 2019 2020 2021 2022 2023
Advertising Jan-19 Dec-23 Monthly 10,000 1% 1% 1% 1%
Utilities Jan-19 Dec-23 Monthly 5,000 1% 1% 1% 1%
Rent Jan-19 Dec-23 Monthly 50,000 1% 1% 1% 1%
Medical Director Fee Jan-19 Dec-23 Monthly 10,000 1% 1% 1% 1%
Software Jan-19 Dec-23 Monthly 3,000 1% 1% 1% 1%
Miscellaneous Jan-19 Dec-23 Monthly 1,000 1% 1% 1% 1%
FC_Placeholder7 Jan-19 Dec-23 Monthly 100,000 1% 1% 1% 1%
FC_Placeholder8 Jan-19 Dec-23 Monthly
Built with finmodelslab.com template Store General Expense assumptions 09/22/2021

Wages
Model Name
Salaries & Wages - Assumptions, $
Staff Numbers by years

Staff numbers Annual Salary raise Monthly Tax Rate,
Annual
Categories Hire Fire 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 Bonus, % %
Salary, $
Director Jan-19 Dec-23 100,000 1.0 1.0 1.0 1.0 1.0 1% 1% 1% 1% 3.0% 10.0%
Lead Nurse Jan-19 Dec-23 90,000 2.0 2.0 3.0 3.0 4.0 1% 1% 1% 1% 5.0% 10.0%
Nurse Jan-19 Dec-23 60,000 1.0 2.0 2.0 3.0 3.0 1% 1% 1% 1% 2.0% 10.0%
Office staff Jan-19 Dec-23 45,000 1.0 1.0 2.0 2.0 2.0 1% 1% 1% 1% 10.0%
Hyperbaric Tech Jan-19 Dec-23 45,000 1.0 1.0 2.0 2.0 2.0 1% 1% 1% 1% 10.0%
Additional Staff Jan-19 Dec-23 10,000 1.0 2.0 2.0 2.0 2.0 1% 1% 1% 1% 10.0%
HC_Placeholder7 Jan-19 Dec-23
Total Staff 7.0 9.0 12.0 13.0 14.0
Built with finmodelslab.com template Wages 09/22/2021

Development Expenses
Model Name
Development Expenses - Assumptions

Clinics
Categories Purchase date Pmnt Delay Spending, $
Company setup
Booking / loyalty program Jan-19 0M 10,000
Lookbook Feb-19 1M 2,100
Homepage Apr-19 2M 3,200
CVI May-19 3M 65,000
Interior Design Style Guide Jun-19 1M 2,700
Built with finmodelslab.com template Development Expenses 09/22/2021

Book Assets
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
Assets - Assumptions
Launch
Categories Useful time, Years Opening Balance/Cost, $
date
Clinic Development 1 83,000
Book Assets - Assumptions, $

12 12 12 12 12 12 12 12 12 12 12 12
Book Assets Category 1 Assumptions
Category Name Clinic Development

1 Years, Straight Line
Opening Net Book Value - 9,167 10,258 9,250 11,175 69,483 65,267 58,350 51,433 44,517 37,600 30,683
Capital Expenditure 10,000 2,100 - 3,200 65,000 2,700 - - - - - -
Book Depreciation 833 1,008 1,008 1,275 6,692 6,917 6,917 6,917 6,917 6,917 6,917 6,917
Closing Net Book Value - 9,167 10,258 9,250 11,175 69,483 65,267 58,350 51,433 44,517 37,600 30,683 23,767
- - - - - - - - - - - -
Category Name -
- Years, Straight Line
Opening Net Book Value - - - - - - - - - - - -
Capital Expenditure - - - - - - - - - - - -
Book Depreciation - - - - - - - - - - - -
Closing Net Book Value - - - - - - - - - - - - -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
Built with finmodelslab.com template BooK Assets 09/22/2021

Book Assets
Model Name
Fiscal Year 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
Launch
Categories Useful time, Years
date
Clinic Development 1

12 12 12 12 12 12 12 12 12 12 12 12

Opening Net Book Value 23,767 17,683 11,775 5,867 225 0 0 0 0 0 0 0
Book Depreciation 6,083 5,908 5,908 5,642 225 - - - - - - -
Closing Net Book Value - 17,683 11,775 5,867 225 0 0 0 0 0 0 0 0
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -

Book Assets
Model Name
Fiscal Year 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021
Launch
date

12 12 12 12 12 12 12 12 12 12 12 12

Opening Net Book Value 0 0 0 0 0 0 0 0 0 0 0 0
Closing Net Book Value - 0 0 0 0 0 0 0 0 0 0 0 0
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -

Book Assets
Model Name
Fiscal Year 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022
Launch
date

12 12 12 12 12 12 12 12 12 12 12 12

- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -

Book Assets
Model Name
Fiscal Year 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
Launch
date

12 12 12 12 12 12 12 12 12 12 12 12

- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -
- - - - - - - - - - - -
Category Name -

Capitalization Table
Model Name
Date Jan-18 Date Jul-18 Date Mar-18

Cost/share, $ 1 Cost/share, $ 1 Cost/share, $ 1 Cost/share, $
Total Shares Issued 500,000 Total Shares Issued 0 Total Shares Issued 0 Total Shares Issued
Total Equity Raised, $ 500,000 Total Equity Raised, $ 500,000 Total Equity Raised, $ 500,000 Total Equity Raised, $
Round Value (total shares x round cost), $ 500,000 Round Value (total shares x round cost), $ 0 Round Value (total shares x round cost), $ 0 Round Value (total shares x round cost), $
Founders Series A Series B Series C

Total Total
Date of Number % of Date of Number % of Date of Number % of Date of Number
Shareholder Name Investment, $ Investment, $ Number of Investment, $ Number of Investment, $
Issue of Shares Total Issue of Shares Total Issue of Shares Total Issue of Shares
Shares Shares
Placeholder1 Jan-18 500,000 500,000 100.00% Jul-18 - 500,000 100.00% Mar-18 - 500,000 100.00% Apr-22 -
Initial SH
Placeholder2 Jan-18 - 0.00% Jul-18 - 0 0.00% Mar-18 - 0 0.00% Apr-22 -

Subtotal: Initial 500,000 500,000 100.00% - 0 500,000 100.00% - 0 500,000 100.00% - 0
Placeholder6 Jul-18 - 0 0.00% Mar-18 - 0 0.00% Apr-22 -

Subtotal: Series A - 0 0 0.00% - 0 0 0.00% - 0
Investor Shareholders
Placeholder11 Mar-18 - 0 0.00% Apr-22 -

Subtotal: Series B - 0 0 0.00% - 0
Placeholder16 Apr-22 -
Subtotal: Series C - 0
Subtotal: Investors - 0 100.00% - - - 100.00% - - - 100.00% - -
TOTAL SHARES 500,000 500,000 500,000 500,000
Pre-money Total Equity, $ - 500,000 500,000 500,000

Post-money Total Equity, $ 500,000 500,000 500,000 500,000
Built with finmodelslab.com template Capitalization Table 09/22/2021

Date Apr-22
Cost/share, $ 1
Total Shares Issued -
Total Equity Raised, $ 150,000
shares x round cost), $ -
Series C
Total
% of
Number of
Total
Shares
500,000 100.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
500,000 100.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
0 0.00%
- 100.00%
Built with finmodelslab.com template Capitalization Table 09/22/2021

Revenue Calculation
Model Name
Population
2019 2020 2021 2022 2023
Growth rate of population initial year 5% 5% 5% 5%
Population 80,000 84,000 88,200 92,610 97,240
Patients
2019 2020 2021 2022 2023
Disease #1 35% 36% 38% 40% 43%
Disease #2 15% 16% 17% 18% 19%
Disease #1 1,400 1,512 1,675 1,852 2,090

Disease #2 1,800 2,016 2,249 2,500 2,771
3,200 3,528 3,924 4,352 4,861
New Patients
2019 2020 2021 2022 2023
Disease #1 1,400 112 163 177 238
Disease #2 1,800 216 233 251 271
3,200 328 396 428 509
Estimated Revenue, $
2019 2020 2021 2022 2023
Disease #1 1,592,500 3,067,400 3,600,656 3,984,469 4,457,063
Disease #2 731,250 1,437,750 1,606,656 1,788,719 1,985,094
2,323,750 4,505,150 5,207,313 5,773,188 6,442,156
Built with finmodelslab.com template Revenue Assumption 09/22/2021

Outputs
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
New Patients
Disease #1 117 117 117 117 117 117 117 117 117 117 117 117
Disease #2 150 150 150 150 150 150 150 150 150 150 150 150
Total New Patients 267 267 267 267 267 267 267 267 267 267 267 267
Active Patients
Disease #1 117 233 350 467 583 700 817 933 1,050 1,167 1,283 1,400
Disease #2 150 300 450 600 750 900 1,050 1,200 1,350 1,500 1,650 1,800
Total Active Patients 267 533 800 1,067 1,333 1,600 1,867 2,133 2,400 2,667 2,933 3,200
Number Of Visits
Disease #1 292 583 875 1,167 1,458 1,750 2,042 2,333 2,625 2,917 3,208 3,500
Disease #2 313 625 938 1,250 1,563 1,875 2,188 2,500 2,813 3,125 3,438 3,750
Total Number Of Visits 604 1,208 1,813 2,417 3,021 3,625 4,229 4,833 5,438 6,042 6,646 7,250
Revenue, $
Disease #1 20,417 40,833 61,250 81,667 102,083 122,500 142,917 163,333 183,750 204,167 224,583 245,000
Disease #2 9,375 18,750 28,125 37,500 46,875 56,250 65,625 75,000 84,375 93,750 103,125 112,500
Total Revenue, $ 29,792 59,583 89,375 119,167 148,958 178,750 208,542 238,333 268,125 297,917 327,708 357,500
Total Staff Numbers
Director 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Lead Nurse 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Nurse 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Office staff 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Hyperbaric Tech 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Additional Staff 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -
Total Total Staff Numbers 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0
Monthly Base Salaries, $
Director 8,333 8,333 8,333 8,333 8,333 8,333 8,333 8,333 8,333 8,333 8,333 8,333
Lead Nurse 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000 15,000
Nurse 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000
Office staff 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750
Hyperbaric Tech 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750
Additional Staff 833 833 833 833 833 833 833 833 833 833 833 833
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -
Built with finmodelslab.com template Outputs 09/22/2021

Outputs
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -
Total Monthly Base Salaries, $ 36,667 36,667 36,667 36,667 36,667 36,667 36,667 36,667 36,667 36,667 36,667 36,667

Outputs
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
Fixed Expenses, $
Advertising 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000
Utilities 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000 5,000
Rent 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000
Medical Director Fee 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000 10,000
Software 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000
Miscellaneous 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000
FC_Placeholder7 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000
FC_Placeholder8 - - - - - - - - - - - -
FC_Placeholder9 - - - - - - - - - - - -
FC_Placeholder10 - - - - - - - - - - - -
FC_Placeholder11 - - - - - - - - - - - -
FC_Placeholder12 - - - - - - - - - - - -
FC_Placeholder13 - - - - - - - - - - - -
FC_Placeholder14 - - - - - - - - - - - -
FC_Placeholder15 - - - - - - - - - - - -
Total Fixed Expenses, $ 179,000 179,000 179,000 179,000 179,000 179,000 179,000 179,000 179,000 179,000 179,000 179,000
Payment processing 745 1,490 2,234 2,979 3,724 4,469 5,214 5,958 6,703 7,448 8,193 8,938
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 2,917 5,833 8,750 11,667 14,583 17,500 20,417 23,333 26,250 29,167 32,083 35,000
VC_Placeholder4 2,333 4,667 7,000 9,333 11,667 14,000 16,333 18,667 21,000 23,333 25,667 28,000
VC_Placeholder5 1,563 3,125 4,688 6,250 7,813 9,375 10,938 12,500 14,063 15,625 17,188 18,750
VC_Placeholder6 - - - - - - - - - - - -
Charts data ($'000)
CASH INFLOW 30 60 89 119 149 179 209 238 268 298 328 358
CASH OUTFLOW (228) (236) (244) (251) (259) (266) (274) (281) (289) (296) (304) (312)
CASH (158) (336) (494) (627) (738) (831) (900) (1,009) (1,031) (1,031) (1,009) (964)
Disease #1 20.4 40.8 61.3 81.7 102.1 122.5 142.9 163.3 183.8 204.2 224.6 245.0
Disease #2 9.4 18.8 28.1 37.5 46.9 56.3 65.6 75.0 84.4 93.8 103.1 112.5
Revenue 30 60 89 119 149 179 209 238 268 298 328 358
Variable Expenses, $ (8) (15) (23) (30) (38) (45) (53) (60) (68) (76) (83) (91)
EBITDA (198) (176) (154) (132) (109) (87) (65) (43) (20) 2 24 46
EBIT (199) (177) (155) (133) (116) (94) (72) (50) (27) (5) 17 39
Net Profit After Tax (199) (177) (155) (133) (116) (94) (72) (50) (28) (5) 17 39
OPEX (221) (221) (221) (221) (221) (221) (221) (221) (221) (221) (221) (221)
OPEX per one patient 859 445 306 237 199 171 150 135 123 114 106 100
OPEX per one visit 379 196 135 104 88 75 66 60 54 50 47 44
Revenue per one Disease #1 patient 0.18 0.18 0.18 0.18 0.18 0.18 0.18 0.18 0.18 0.18 0.18 0.18
OPEX per one Disease #1 patient 2.0 1.0 0.7 0.5 0.5 0.4 0.3 0.3 0.3 0.3 0.2 0.2
Revenue per employee 4.3 8.5 12.8 17.0 21.3 25.5 29.8 34.0 38.3 42.6 46.8 51.1
OPEX per employee 32.7 33.9 34.9 36.1 37.9 39.0 40.1 41.2 42.3 43.3 44.4 45.5

Outputs
Model Name
Fiscal Year 2019 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
New Patients
Disease #1 9 9 9 9 9 9 9 9 9 9 9 9
Disease #2 18 18 18 18 18 18 18 18 18 18 18 18
Active Patients
Disease #1 1,409 1,419 1,428 1,437 1,447 1,456 1,465 1,475 1,484 1,493 1,503 1,512
Disease #2 1,818 1,836 1,854 1,872 1,890 1,908 1,926 1,944 1,962 1,980 1,998 2,016
Total Active Patients 3,227 3,255 3,282 3,309 3,337 3,364 3,391 3,419 3,446 3,473 3,501 3,528
Number Of Visits
Disease #1 3,523 3,547 3,570 3,593 3,617 3,640 3,663 3,687 3,710 3,733 3,757 3,780
Disease #2 3,788 3,825 3,863 3,900 3,938 3,975 4,013 4,050 4,088 4,125 4,163 4,200
Total Number Of Visits 7,311 7,372 7,433 7,493 7,554 7,615 7,676 7,737 7,798 7,858 7,919 7,980
Revenue, $
Disease #1 246,633 248,267 249,900 251,533 253,167 254,800 256,433 258,067 259,700 261,333 262,967 264,600
Disease #2 113,625 114,750 115,875 117,000 118,125 119,250 120,375 121,500 122,625 123,750 124,875 126,000
Total Revenue, $ 360,258 363,017 365,775 368,533 371,292 374,050 376,808 379,567 382,325 385,083 387,842 390,600
Total Staff Numbers
Director 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Lead Nurse 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Nurse 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Office staff 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Hyperbaric Tech 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -
Director 8,417 8,417 8,417 8,417 8,417 8,417 8,417 8,417 8,417 8,417 8,417 8,417
Lead Nurse 15,150 15,150 15,150 15,150 15,150 15,150 15,150 15,150 15,150 15,150 15,150 15,150
Nurse 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100
Office staff 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788
Hyperbaric Tech 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788 3,788
Additional Staff 1,683 1,683 1,683 1,683 1,683 1,683 1,683 1,683 1,683 1,683 1,683 1,683
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
Fixed Expenses, $
Advertising 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100 10,100
Utilities 5,050 5,050 5,050 5,050 5,050 5,050 5,050 5,050 5,050 5,050 5,050 5,050
Rent 50,500 50,500 50,500 50,500 50,500 50,500 50,500 50,500 50,500 50,500 50,500 50,500
Software 3,030 3,030 3,030 3,030 3,030 3,030 3,030 3,030 3,030 3,030 3,030 3,030
Miscellaneous 1,010 1,010 1,010 1,010 1,010 1,010 1,010 1,010 1,010 1,010 1,010 1,010
FC_Placeholder7 101,000 101,000 101,000 101,000 101,000 101,000 101,000 101,000 101,000 101,000 101,000 101,000
FC_Placeholder8 - - - - - - - - - - - -
FC_Placeholder9 - - - - - - - - - - - -
FC_Placeholder10 - - - - - - - - - - - -
FC_Placeholder11 - - - - - - - - - - - -
FC_Placeholder12 - - - - - - - - - - - -
FC_Placeholder13 - - - - - - - - - - - -
FC_Placeholder14 - - - - - - - - - - - -
FC_Placeholder15 - - - - - - - - - - - -
Payment processing 9,006 9,075 9,144 9,213 9,282 9,351 9,420 9,489 9,558 9,627 9,696 9,765
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 35,233 35,467 35,700 35,933 36,167 36,400 36,633 36,867 37,100 37,333 37,567 37,800
VC_Placeholder4 28,187 28,373 28,560 28,747 28,933 29,120 29,307 29,493 29,680 29,867 30,053 30,240
VC_Placeholder5 18,938 19,125 19,313 19,500 19,688 19,875 20,063 20,250 20,438 20,625 20,813 21,000
VC_Placeholder6 - - - - - - - - - - - -
Charts data ($'000)
CASH INFLOW 360 363 366 369 371 374 377 380 382 385 388 391
CASH OUTFLOW (324) (325) (326) (327) (328) (329) (330) (331) (332) (333) (334) (335)
CASH (930) (893) (855) (815) (774) (730) (685) (638) (589) (463) (410) (355)
Disease #1 246.6 248.3 249.9 251.5 253.2 254.8 256.4 258.1 259.7 261.3 263.0 264.6
Disease #2 113.6 114.8 115.9 117.0 118.1 119.3 120.4 121.5 122.6 123.8 124.9 126.0
Revenue 360 363 366 369 371 374 377 380 382 385 388 391
EBITDA 40 42 44 46 48 50 52 54 56 58 60 62
EBIT 33 36 38 40 48 50 52 54 56 58 60 62
Net Profit After Tax 30 32 34 36 43 45 47 49 50 52 54 56
OPEX (229) (229) (229) (229) (229) (229) (229) (229) (229) (229) (229) (229)


Outputs
Model Name
Fiscal Year 2019 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021
New Patients
Disease #1 14 14 14 14 14 14 14 14 14 14 14 14
Disease #2 19 19 19 19 19 19 19 19 19 19 19 19
Active Patients
Disease #1 1,526 1,539 1,553 1,566 1,580 1,594 1,607 1,621 1,634 1,648 1,661 1,675
Disease #2 2,035 2,055 2,074 2,094 2,113 2,133 2,152 2,171 2,191 2,210 2,230 2,249
Number Of Visits
Disease #1 3,814 3,848 3,882 3,916 3,950 3,984 4,018 4,052 4,086 4,120 4,154 4,188
Disease #2 4,240 4,281 4,321 4,362 4,402 4,443 4,483 4,524 4,564 4,605 4,645 4,685
Revenue, $
Disease #1 286,047 288,594 291,141 293,688 296,234 298,781 301,328 303,875 306,422 308,969 311,516 314,063
Disease #2 127,214 128,427 129,641 130,854 132,068 133,281 134,495 135,708 136,922 138,135 139,349 140,563
Total Revenue, $ 413,260 417,021 420,781 424,542 428,302 432,063 435,823 439,583 443,344 447,104 450,865 454,625
Total Staff Numbers
Director 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Lead Nurse 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
Nurse 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Office staff 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Hyperbaric Tech 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -
Director 8,501 8,501 8,501 8,501 8,501 8,501 8,501 8,501 8,501 8,501 8,501 8,501
Lead Nurse 22,952 22,952 22,952 22,952 22,952 22,952 22,952 22,952 22,952 22,952 22,952 22,952
Nurse 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201
Office staff 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651
Hyperbaric Tech 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651 7,651
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021
Fixed Expenses, $
Advertising 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201 10,201
Utilities 5,101 5,101 5,101 5,101 5,101 5,101 5,101 5,101 5,101 5,101 5,101 5,101
Rent 51,005 51,005 51,005 51,005 51,005 51,005 51,005 51,005 51,005 51,005 51,005 51,005
Software 3,060 3,060 3,060 3,060 3,060 3,060 3,060 3,060 3,060 3,060 3,060 3,060
Miscellaneous 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020 1,020
FC_Placeholder7 102,010 102,010 102,010 102,010 102,010 102,010 102,010 102,010 102,010 102,010 102,010 102,010
FC_Placeholder8 - - - - - - - - - - - -
FC_Placeholder9 - - - - - - - - - - - -
FC_Placeholder10 - - - - - - - - - - - -
FC_Placeholder11 - - - - - - - - - - - -
FC_Placeholder12 - - - - - - - - - - - -
FC_Placeholder13 - - - - - - - - - - - -
FC_Placeholder14 - - - - - - - - - - - -
FC_Placeholder15 - - - - - - - - - - - -
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 38,140 38,479 38,819 39,158 39,498 39,838 40,177 40,517 40,856 41,196 41,535 41,875
VC_Placeholder4 30,512 30,783 31,055 31,327 31,598 31,870 32,142 32,413 32,685 32,957 33,228 33,500
VC_Placeholder5 21,202 21,405 21,607 21,809 22,011 22,214 22,416 22,618 22,820 23,023 23,225 23,427
VC_Placeholder6 - - - - - - - - - - - -
Charts data ($'000)
CASH INFLOW 413 417 421 425 428 432 436 440 443 447 451 455
CASH OUTFLOW (356) (357) (358) (359) (360) (362) (363) (364) (365) (366) (367) (369)
CASH (299) (240) (179) (115) (48) 21 93 167 244 323 405 490
Disease #1 286.0 288.6 291.1 293.7 296.2 298.8 301.3 303.9 306.4 309.0 311.5 314.1
Disease #2 127.2 128.4 129.6 130.9 132.1 133.3 134.5 135.7 136.9 138.1 139.3 140.6
Revenue 413 417 421 425 428 432 436 440 443 447 451 455
EBITDA 64 67 70 73 76 78 81 84 87 90 93 96
EBIT 64 67 70 73 76 78 81 84 87 90 93 96
OPEX (249) (249) (249) (249) (249) (249) (249) (249) (249) (249) (249) (249)


Outputs
Model Name
Fiscal Year 2019 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022
New Patients
Disease #1 15 15 15 15 15 15 15 15 15 15 15 15
Disease #2 21 21 21 21 21 21 21 21 21 21 21 21
Active Patients
Disease #1 1,690 1,705 1,719 1,734 1,749 1,764 1,778 1,793 1,808 1,823 1,837 1,852
Disease #2 2,270 2,291 2,312 2,333 2,354 2,375 2,395 2,416 2,437 2,458 2,479 2,500
Number Of Visits
Disease #1 4,224 4,261 4,298 4,335 4,372 4,409 4,446 4,483 4,519 4,556 4,593 4,630
Disease #2 4,729 4,773 4,816 4,860 4,903 4,947 4,990 5,034 5,078 5,121 5,165 5,208
Revenue, $
Disease #1 316,828 319,594 322,359 325,125 327,891 330,656 333,422 336,188 338,953 341,719 344,484 347,250
Disease #2 141,870 143,177 144,484 145,792 147,099 148,406 149,714 151,021 152,328 153,635 154,943 156,250
Total Revenue, $ 458,698 462,771 466,844 470,917 474,990 479,063 483,135 487,208 491,281 495,354 499,427 503,500
Total Staff Numbers
Director 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Lead Nurse 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
Nurse 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
Office staff 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Hyperbaric Tech 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -
Director 8,586 8,586 8,586 8,586 8,586 8,586 8,586 8,586 8,586 8,586 8,586 8,586
Lead Nurse 23,182 23,182 23,182 23,182 23,182 23,182 23,182 23,182 23,182 23,182 23,182 23,182
Nurse 15,455 15,455 15,455 15,455 15,455 15,455 15,455 15,455 15,455 15,455 15,455 15,455
Office staff 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727
Hyperbaric Tech 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727 7,727
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022
Fixed Expenses, $
Advertising 10,303 10,303 10,303 10,303 10,303 10,303 10,303 10,303 10,303 10,303 10,303 10,303
Utilities 5,152 5,152 5,152 5,152 5,152 5,152 5,152 5,152 5,152 5,152 5,152 5,152
Rent 51,515 51,515 51,515 51,515 51,515 51,515 51,515 51,515 51,515 51,515 51,515 51,515
Software 3,091 3,091 3,091 3,091 3,091 3,091 3,091 3,091 3,091 3,091 3,091 3,091
Miscellaneous 1,030 1,030 1,030 1,030 1,030 1,030 1,030 1,030 1,030 1,030 1,030 1,030
FC_Placeholder7 103,030 103,030 103,030 103,030 103,030 103,030 103,030 103,030 103,030 103,030 103,030 103,030
FC_Placeholder8 - - - - - - - - - - - -
FC_Placeholder9 - - - - - - - - - - - -
FC_Placeholder10 - - - - - - - - - - - -
FC_Placeholder11 - - - - - - - - - - - -
FC_Placeholder12 - - - - - - - - - - - -
FC_Placeholder13 - - - - - - - - - - - -
FC_Placeholder14 - - - - - - - - - - - -
FC_Placeholder15 - - - - - - - - - - - -
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 42,244 42,613 42,981 43,350 43,719 44,088 44,456 44,825 45,194 45,563 45,931 46,300
VC_Placeholder4 33,795 34,090 34,385 34,680 34,975 35,270 35,565 35,860 36,155 36,450 36,745 37,040
VC_Placeholder5 23,645 23,863 24,081 24,299 24,516 24,734 24,952 25,170 25,388 25,606 25,824 26,042
VC_Placeholder6 - - - - - - - - - - - -
Charts data ($'000)
CASH INFLOW 459 463 467 471 475 479 483 487 491 495 499 504
CASH OUTFLOW (377) (379) (380) (381) (383) (384) (385) (386) (388) (389) (390) (392)
CASH 570 654 741 830 923 1,018 1,116 1,217 1,321 1,427 1,536 1,648
Disease #1 316.8 319.6 322.4 325.1 327.9 330.7 333.4 336.2 339.0 341.7 344.5 347.3
Disease #2 141.9 143.2 144.5 145.8 147.1 148.4 149.7 151.0 152.3 153.6 154.9 156.3
Revenue 459 463 467 471 475 479 483 487 491 495 499 504
EBITDA 90 93 97 100 103 106 109 112 115 118 121 124
EBIT 90 93 97 100 103 106 109 112 115 118 121 124
OPEX (257) (257) (257) (257) (257) (257) (257) (257) (257) (257) (257) (257)


Outputs
Model Name
Fiscal Year 2019 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
New Patients
Disease #1 20 20 20 20 20 20 20 20 20 20 20 20
Disease #2 23 23 23 23 23 23 23 23 23 23 23 23
Active Patients
Disease #1 1,872 1,892 1,912 1,931 1,951 1,971 1,991 2,011 2,031 2,050 2,070 2,090
Disease #2 2,523 2,545 2,568 2,590 2,613 2,636 2,658 2,681 2,703 2,726 2,748 2,771
Number Of Visits
Disease #1 4,680 4,729 4,779 4,828 4,878 4,928 4,977 5,027 5,076 5,126 5,175 5,225
Disease #2 5,255 5,302 5,349 5,397 5,444 5,491 5,538 5,585 5,632 5,679 5,726 5,773
Revenue, $
Disease #1 350,969 354,688 358,406 362,125 365,844 369,563 373,281 377,000 380,719 384,438 388,156 391,875
Disease #2 157,661 159,073 160,484 161,896 163,307 164,719 166,130 167,542 168,953 170,365 171,776 173,188
Total Revenue, $ 508,630 513,760 518,891 524,021 529,151 534,281 539,411 544,542 549,672 554,802 559,932 565,063
Total Staff Numbers
Director 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Lead Nurse 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0
Nurse 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
Office staff 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Hyperbaric Tech 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -
Director 8,672 8,672 8,672 8,672 8,672 8,672 8,672 8,672 8,672 8,672 8,672 8,672
Lead Nurse 31,218 31,218 31,218 31,218 31,218 31,218 31,218 31,218 31,218 31,218 31,218 31,218
Nurse 15,609 15,609 15,609 15,609 15,609 15,609 15,609 15,609 15,609 15,609 15,609 15,609
Office staff 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805
Hyperbaric Tech 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805 7,805
HC_Placeholder7 - - - - - - - - - - - -
HC_Placeholder8 - - - - - - - - - - - -
HC_Placeholder9 - - - - - - - - - - - -
HC_Placeholder10 - - - - - - - - - - - -
HC_Placeholder11 - - - - - - - - - - - -
HC_Placeholder12 - - - - - - - - - - - -
HC_Placeholder13 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
HC_Placeholder14 - - - - - - - - - - - -
HC_Placeholder15 - - - - - - - - - - - -
HC_Placeholder16 - - - - - - - - - - - -
HC_Placeholder17 - - - - - - - - - - - -
HC_Placeholder18 - - - - - - - - - - - -
HC_Placeholder19 - - - - - - - - - - - -

Outputs
Model Name
Fiscal Year 2019 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
Fixed Expenses, $
Advertising 10,406 10,406 10,406 10,406 10,406 10,406 10,406 10,406 10,406 10,406 10,406 10,406
Utilities 5,203 5,203 5,203 5,203 5,203 5,203 5,203 5,203 5,203 5,203 5,203 5,203
Rent 52,030 52,030 52,030 52,030 52,030 52,030 52,030 52,030 52,030 52,030 52,030 52,030
Software 3,122 3,122 3,122 3,122 3,122 3,122 3,122 3,122 3,122 3,122 3,122 3,122
Miscellaneous 1,041 1,041 1,041 1,041 1,041 1,041 1,041 1,041 1,041 1,041 1,041 1,041
FC_Placeholder7 104,060 104,060 104,060 104,060 104,060 104,060 104,060 104,060 104,060 104,060 104,060 104,060
FC_Placeholder8 - - - - - - - - - - - -
FC_Placeholder9 - - - - - - - - - - - -
FC_Placeholder10 - - - - - - - - - - - -
FC_Placeholder11 - - - - - - - - - - - -
FC_Placeholder12 - - - - - - - - - - - -
FC_Placeholder13 - - - - - - - - - - - -
FC_Placeholder14 - - - - - - - - - - - -
FC_Placeholder15 - - - - - - - - - - - -
VC_Placeholder2 - - - - - - - - - - - -
VC_Placeholder3 46,796 47,292 47,788 48,283 48,779 49,275 49,771 50,267 50,763 51,258 51,754 52,250
VC_Placeholder4 37,437 37,833 38,230 38,627 39,023 39,420 39,817 40,213 40,610 41,007 41,403 41,800
VC_Placeholder5 26,277 26,512 26,747 26,983 27,218 27,453 27,688 27,924 28,159 28,394 28,629 28,865
VC_Placeholder6 - - - - - - - - - - - -
Charts data ($'000)
CASH INFLOW 509 514 519 524 529 534 539 545 550 555 560 565
CASH OUTFLOW (404) (405) (407) (409) (410) (412) (413) (415) (417) (418) (420) (422)
CASH 1,753 1,862 1,974 2,089 2,208 2,330 2,456 2,586 2,719 2,855 2,995 3,138
Disease #1 351.0 354.7 358.4 362.1 365.8 369.6 373.3 377.0 380.7 384.4 388.2 391.9
Disease #2 157.7 159.1 160.5 161.9 163.3 164.7 166.1 167.5 169.0 170.4 171.8 173.2
Revenue 509 514 519 524 529 534 539 545 550 555 560 565
EBITDA 117 121 124 128 132 136 140 144 148 152 155 159
EBIT 117 121 124 128 132 136 140 144 148 152 155 159
OPEX (269) (269) (269) (269) (269) (269) (269) (269) (269) (269) (269) (269)


Capital
Model Name
Fiscal Year 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2022 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
Month Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21 Jan-22 Feb-22 Mar-22 Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Oct-22 Nov-22 Dec-22 Jan-23 Feb-23 Mar-23 Apr-23 May-23 Jun-23 Jul-23 Aug-23 Sep-23 Oct-23 Nov-23 Dec-23
Capital - Calculation, $
Debt_1
Funds Drawn
Opening Balance - 50,000 48,611 47,222 45,833 44,444 43,056 41,667 40,278 38,889 37,500 36,111 34,722 33,333 31,944 30,556 29,167 27,778 26,389 25,000 23,611 22,222 20,833 19,444 18,056 16,667 15,278 13,889 12,500 11,111 9,722 8,333 6,944 5,556 4,167 2,778 1,389 (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Debt Drawdowns 50,000 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Repayments - (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) - - - - - - - - - - - - - - - - - - - - - - -
Closing Debt Balance 50,000 48,611 47,222 45,833 44,444 43,056 41,667 40,278 38,889 37,500 36,111 34,722 33,333 31,944 30,556 29,167 27,778 26,389 25,000 23,611 22,222 20,833 19,444 18,056 16,667 15,278 13,889 12,500 11,111 9,722 8,333 6,944 5,556 4,167 2,778 1,389 (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Debt Repayments Calculation - 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 1,389 - - - - - - - - - - - - - - - - - - - - - - -
Interest Expense
Interest Expense - 417 405 394 382 370 359 347 336 324 313 301 289 278 266 255 243 231 220 208 197 185 174 162 150 139 127 116 104 93 81 69 58 46 35 23 12 - - - - - - - - - - - - - - - - - - - - - - -
Debt_2
Funds Drawn
Opening Balance - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Drawdowns - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Repayments - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Closing Debt Balance - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Repayments Calculation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Interest Expense
Interest Expense - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt_3
Funds Drawn
Opening Balance - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Drawdowns - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Repayments - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Closing Debt Balance - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Repayments Calculation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Interest Expense
Interest Expense - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Total Debts, $
Funds Drawn
Opening Balance - 50,000 48,611 47,222 45,833 44,444 43,056 41,667 40,278 38,889 37,500 36,111 34,722 33,333 31,944 30,556 29,167 27,778 26,389 25,000 23,611 22,222 20,833 19,444 18,056 16,667 15,278 13,889 12,500 11,111 9,722 8,333 6,944 5,556 4,167 2,778 1,389 (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Debt Drawdowns 50,000 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Repayments - (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) (1,389) - - - - - - - - - - - - - - - - - - - - - - -
Closing Debt Balance 50,000 48,611 47,222 45,833 44,444 43,056 41,667 40,278 38,889 37,500 36,111 34,722 33,333 31,944 30,556 29,167 27,778 26,389 25,000 23,611 22,222 20,833 19,444 18,056 16,667 15,278 13,889 12,500 11,111 9,722 8,333 6,944 5,556 4,167 2,778 1,389 (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Interest Expense
Interest Expense - 417 405 394 382 370 359 347 336 324 313 301 289 278 266 255 243 231 220 208 197 185 174 162 150 139 127 116 104 93 81 69 58 46 35 23 12 - - - - - - - - - - - - - - - - - - - - - - -
Ordinary Equity, $
Ordinary Equity Balances
Opening Balance - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Founders - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Series A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Series B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Series C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Equity Repayments
Closing Ordinary Equity - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Grant, $
Funds Drawn - - - - - - - - - - - - - - - - - - - - - 75,000 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Total Grants, $
Funds Drawn - - - - - - - - - - - - - - - - - - - - - 75,000 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Closing Balance - - - - - - - - - - - - - - - - - - - - - 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000 75,000
Built with finmodelslab.com template Capital 09/22/2021

Time Series
Model Name
Go to Table of Contents
Time Series - Lookups
Month Days Names
Month Day LU_TS_Mth_Days

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Time Series
Model Name
Month Names Names
Month Name LU_TS_Mth_Names

January
February
March
April
May
June
July
August
September
October
November
December
Periods In Periods
Periods In Period
60 TS_Secs_In_Min
60 TS_Mins_In_Hr
24 TS_Hrs_In_Day
7 TS_Days_In_Wk
3 TS_Mths_In_Qtr
6 TS_Mths_In_Half
12 TS_Mths_In_Yr
2 TS_Qtrs_In_Half
4 TS_Qtrs_In_Yr
2 TS_Halves_In_Yr
Denominations Names
Denomination LU_TS_Denom
$
$'000
$'Millions
$'Billions
Denomination Conversions Names
Denomination Conversion LU_TS_Denom_Conv

1
1,000 TS_Thousand
1,000,000 TS_Million
1,000,000,000 TS_Billion

Time Series
Model Name
LU_Exp_Type Names
One time LU_Exp_Type

Daily
Weekly
Bi-Weekly
Monthly
Quarterly
Semi-Annually
Yearly
LU_Launch_Dev_Exp Names
0M LU_Launch_Dev_Exp
1M
2M
3M

Outputs & Other
Model Name
Financial Statements Summary - Lookups
First Displayed Periods Names
First Displayed Period LU_FS_Sum_First_Disp_Per

2019
2020
2021
2022
2023
Top Revenue - Lookups
First Displayed Period LU_Top_Rev_First_Disp_Per

2019
2020
2021
2022
2023
Displayed Periods Names
Displayed Period LU_Top_Rev_Dis_Pers

2019
2020
2021
2022
2023
Top Expenses - Lookups
First Displayed Period LU_Top_Exp_First_Disp_Per

2019
2020
2021
2022
2023
Displayed Periods Names
Displayed Period LU_Top_Exp_Dis_Pers

2019
2020
2021
2022
2023
Debt Type Names
Type LU_Debt_type
Usual
Annuity
Built with finmodelslab.com template Outputs and Other 09/22/2021

Clinic Financial Model Excel Template v10 DEMO

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Clinic Financial Model Excel Template v10 DEMO

Uploaded by

Copyright:

Available Formats

All cells are locked for your safety

some changes in the model, you

Built with finmodelslab.com template Cover 09/22/2021

1 Reports What each tab does

Built with finmodelslab.com template Table of Contents 09/22/2021

v.9 - 22 Apr 2019

v.7 - 11 Mar 2019

v.6 - 20 Feb 2019

v.4 - 3 Jan 2019

v.1 - 22 Oct 2018

Built with finmodelslab.com template Change Log 09/22/2021

CLINIC FINANCIAL MODEL

Questions, comments, ideas, email henry@finmodelslab.com

WARRANTIES & TERMS OF USE

Built with finmodelslab.com template Information 09/22/2021

This is a guide on how to use the model.

Overall Business Model Principles

Core revenue assumptions are:

CURRENCY, DENOMINATOR and TAX:

Built with finmodelslab.com template How to 09/22/2021

Financial Statements Summary

Break Even Analysis

Learn more at https://finmodelslab.com or email henry@finmodelslab.com with questions.

Built with finmodelslab.com template How to 09/22/2021

Time Series - Assumptions

Fiscal Year End December

Built with finmodelslab.com template Time Series 09/22/2021

Built with finmodelslab.com template Dashboard 09/22/2021

Built with finmodelslab.com template Financial Statements Summary 09/22/2021

Built with finmodelslab.com template Financial Statements Summary 09/22/2021

Built with finmodelslab.com template Financial Statements Summary 09/22/2021

Revenue Summary ($'000) - 5 Years to December 2023

Revenue Summary ($'000) - 5 Years to December 2023

Revenue Depth ($'000) - 2019 Monthly Run-Rate ($'000) - 2019

Revenue Bridge ($'000) - 2019 Total Revenue to 2023 Total Revenue

Built with finmodelslab.com template Top Revenue 09/22/2021

Top 5 Expense Categories ($'000) - 5 Years to December 2023

Top 5 Expense Categories ($'000) - 5 Years to December 2023

Expenses Depth ($'000) - 2019 Monthly Run-Rate ($'000) - 2019

Expenses Bridge ($'000) - 2019 Total Expenses to 2023 Total Expenses

Built with finmodelslab.com template Top Expenses 09/22/2021

BREAK EVEN ($'000)

BREAK EVEN CALCULATION ($'000)

Year 2019 2020 2021 2022 2023

Revenue 2,324 4,505 5,207 5,773 6,442

Built with finmodelslab.com template Break Even Analysis 09/22/2021

Expected annual growth after 2022 3.00%

Free Cash Flow Calculation ($'000)

Free Cash Flow Valuation ($'000)

Discounted Cash Flow ($'000)

NPV based on year 5 18,701

Built with finmodelslab.com template Valuation 09/22/2021

Built with finmodelslab.com template Financial Charts 09/22/2021

Built with finmodelslab.com template Financial Charts 09/22/2021

Built with finmodelslab.com template Operational Charts 09/22/2021

Built with finmodelslab.com template Operational Charts 09/22/2021

Income Statement ($)

Tax Expense at 12### - - - - - - - - - - - -

Built with finmodelslab.com template Income Statement 09/22/2021

Income Statement ($)

Total Depreciation & Amortization (6,083) (5,908) (5,908) (5,642) (225) - - - - - - -

Built with finmodelslab.com template Income Statement 09/22/2021

Income Statement ($)

Total Depreciation & Amortization - - - - - - - - - - - -